Expression levels of TGF-β1, fibronectin, collagen IV, and BMP-7 as well as antioxidative effects of XCHT treatment were examined in order to explore the renal protective effect and mechanism of XCHT in diabetic nephropathy. This evidence concerns the gene TGFB1 and diabetic kidney disease.